CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax. Support extension of R&D tax credit. Oppose repeal of Orphan Drug Tax Credit. Support extension of biofuel and biodiesel tax credits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Health Issues HCR
FDA review process consistency and predictability. Support reauthorization of FDA user fee programs. Oppose changes to weaken federal oversight of compounded drugs (FFDCA Sec. 503B).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Copyright/Patent/Trademark CPT
Address concerns with provisions of patent litigation reform, including inter partes review. Educate on Bayh-Dole Act "march-in" provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Environment/Superfund ENV
Support Consumer and Fuel Retailer Choice Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Medical/Disease Research/Clinical Labs MED
Support NIH research funding. Support implementation of 21st Century Cures Act. Support legislation to improve medical device facility inspections processes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Veterans VET
Address concerns with late payments for medical devices procured by the Department of Veterans Affairs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Medicare/Medicaid MMM
Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support the Ensuring Patient Access to Critical Breakthrough Products Act. Address concerns with proposed HOPPS and PFS rules regarding date of service for advance diagnostic tests, payment classification for drug coated balloon angioplasties, and biosimilars payment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| ADAM LOTSPIKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.